Advertisement
Home Tags Heart / Stroke-Related: Misc.

Tag: Heart / Stroke-Related: Misc.

For patients with new-onset postoperative atrial fibrillation

ACC: Rate, Rhythm Control Both Effective for Post-Op A-Fib

Equal number of days of hospitalization, similar complication and persistent a-fib rates
Early intravenous metoprolol before primary percutaneous coronary intervention does not reduce infarct size in a population with ST-segment elevation myocardial infarction

ACC: Pre-pPCI Metoprolol Doesn’t Reduce Infarct Size in STEMI

Metoprolol cut incidence of malignant arrhythmias; was not linked to increase in adverse events
A community pharmacy-based intervention can reduce cardiovascular disease risk among high-risk patients

ACC: Pharmacist Intervention Can Cut Cardiovascular Risk

Twenty-one percent decrease in CVD risk after adjustment for baseline values, center effect
For patients with suspected coronary artery disease

ACC: Prognostic Value of Cardiac Noninvasive Tests Vary by Sex

Women seem to derive more prognostic value from computed tomographic angiography
For patients with acute myocardial infarction

ACC: Losmapimod Doesn’t Cut Cardio Events After Acute MI

In part A of trial, no reduction in risk of composite of cardiovascular death, MI, severe recurrent ischemia
For intermediate-risk patients with severe aortic stenosis

ACC: TAVR Similar to Surgery for Intermediate-Risk Patients

Similar rate of any-cause death, disabling stroke for intermediate-risk patients with severe aortic stenosis

March 2016 Briefing – Cardiology

Here are what the editors at HealthDay consider to be the most important developments in Cardiology for March 2016. This roundup includes the latest...
Oral estradiol therapy is associated with less progression of subclinical atherosclerosis in postmenopausal women when therapy is initiated early in menopause

Early Menopause Estradiol Tx Cuts Atherosclerosis Advance

Positive effect seen only on carotid-artery intima-media thickness
A new prediction rule may inform which patients will see a benefit or harm from dual antiplatelet therapy beyond one year after percutaneous coronary intervention

Tool Guides Duration of Dual Antiplatelet Therapy After PCI

For patients without major bleed, ischemic event at one year after percutaneous coronary intervention
The 2011 criteria improve diagnosis of long QT syndrome

2011 Criteria Facilitate Diagnosis of Long QT Syndrome

2011 LQTS diagnostic criteria can identify more mutation carriers as being at high probability of LQTS